Yahoo5 Eylül 2026 03:18 TR8 saat önce
Is Moderna (MRNA) Fully Valued After Its New 2032 Convertible Notes?
Moderna (MRNA) drew fresh attention after completing a US$2.6b zero coupon convertible notes offering due 2032 and separately announcing an additional US$2b 2032 convertible notes issue, both placed under Rule 144A. Moderna's recent completion of zero coupon notes and the additional 2032 convertible announcement come after a surge in momentum, with the share price delivering a 30 day return of 158.73% and a year to date share price return of 371.65%, while the 1 year total shareholder return...
Haberin Tamamı Kaynağında
Burada gördüğün özet, haber sağlayıcısından geliyor; metnin devamı yayıncının sitesinde — Yahoo
Haberde Geçen Şirketler
Benzer Haberler
What Does Moderna (MRNA) Bird Flu Phase 3 Trial Mean For Its Growth?
Yahoo4 saat önce
Why Atlassian Stock Skyrocketed 92% Higher in August and Why There's Likely More to Come
Yahoo1 saat önce
CEO Brian Niccol Just Announced Incredible News for Starbucks Investors
Yahoo1 saat önce
Here's How Many Shares of Coca-Cola You'd Need for $40,000 in Yearly Dividends
Yahoo2 saat önce
Berkshire Hathaway Outperformed the S&P 500 Over a 60-Year Period Under Warren Buffett. Here's the Stock That Could Help Continue the Streak Under Greg Abel.
Yahoo3 saat önce